Flagship Pioneering related stories
All articles and analysis
Codiak BioSciences nets $76.5 mln Series CCodiak BioSciences Inc, an exosome therapeutics company, has secured $76.5 million in Series C financing. Codiak's investors include ARCH Venture Partners, Flagship Pioneering, Fidelity Management and Research Company, the Alaska Permanent Fund, Alexandria Venture Investments, Qatar Investment Authority, Boxer Capital of the Tavistock Group, Sirona Capital, EcoR1 Capital and Casdin Capital.
- Torque collects $25 mln Series A
Cambridge, Massachusetts-based Torque, an immuno-oncology company, has raised $25 million in Series A funding. The investor was Flagship Pioneering.
CTI Life Sciences invests in Visterra's $46.7 mln Series CU.S. clinical-stage biotechnology company Visterra Inc has wrapped up its Series C financing, raising US$46.7 million in total. The round was backed by existing and new investors. The latter include CTI Life Sciences, a Canadian life sciences venture capital firm. Founded in 2007, Cambridge, Massachusetts-based Visterra is the creator of the Hierotope platform, which identifies unique disease targets and designs and engineers effective therapeutics. The company will use the round's proceeds to focus on its two lead product candidates and further leverage its platform.
- Biotech company Visterra scores $46.7 mln Series C
Cambridge, Massachusetts-based Visterra Inc, a biotech company, has closed its Series C funding round at $46.7 million. The investors included the Bill & Melinda Gates Foundation, MRL Ventures Fund, Vertex Venture Holdings Ltd., Polaris Partners, Flagship Pioneering, Omega Funds, Cycad Group and Alexandria Venture Investments.
- KSQ Therapeutics rakes in $76 mln
Cambridge, Massachusetts-based KSQ Therapeutics, a provider of a genome-scale precision functional genomics platform, has secured $76 million in funding. Flagship Pioneering; Polaris Partners, ARCH Venture Partners and Alexandria Equities led the round.
- Indigo Ag racks up $156 mln Series D
Boston-based Indigo Ag Inc, which helps farmers "sustainably feed the planet" has secured $156 million in Series D financing. The investors included Baillie Gifford, Activant Capital, Flagship Pioneering and the Alaska Permanent Fund. J.P. Morgan was the placement agent.
- Flagship Pioneering to raise $500 mln for sixth fund
Flagship Pioneering has set a $500 million target for its sixth fund, according to an SEC filing https://www.sec.gov/Archives/edgar/data/1716926/000171692617000001/xslFormDX01/primary_doc.xml The Cambridge, Massachusetts-based venture firm invests in the biotech, healthcare and software sectors.
- Evelo Biosciences rakes in $50 mln Series B
Cambridge, Massachusetts-based Evelo Biosciences, a biotech company, has closed $50 million in Series B financing round. The investors included Flagship Pioneering, GV, Celgene, Mayo Clinic and Alexandria Venture Investments.
- Rubius Therapeutics reels in $120 mln
Cambridge, Massachusetts-based biotech firm Rubius Therapeutics has raised $120 million in financing. The investors included Flagship Pioneering.
- Flagship Pioneering taps JP Morgan's ex-investment banking vice chair as exec partner
Cambridge, Massachusetts-based Flagship Pioneering (formerly known as Flagship Ventures), has appointed Stephen Berenson as an executive partner. Berenson is the former vice chairman of investment banking at JP Morgan. Berenson worked at JP Morgan for more than 33 years.